Skip to main content
. 2021 Sep 29;33(7):2005–2012. doi: 10.1007/s00192-021-04987-5

Table 1.

Patient characteristics, N = 47

All subjects (N = 47) SSLH (N = 30) USLH (N = 17) p value
Age at surgery (years) 52.8 ± 12.5 54.1 ± 2.3 50.4 ± 3.0 0.17
Body mass index (kg/m2) 26.8 ± 4.5 27.4 ± 4.4 25.9 ± 4.8 0.15
Vaginal parity 2 (1–8) 2 (1–5) 2 (1–8) 0.13
Menopause 63.8% (30) 70.0% (21) 52.9% (9) 0.34
Tobacco use 2.1% (1) 3.3% (1) 0% (0) 1.00
Diabetes 8.5% (4) 10.0% (3) 5.9% (1) 1.00
Coronary artery disease 4.3% (2) 3.3% (1) 5.9% (1) 1.00
Asthma, COPD 6.4% (3) 6.7% (2) 5.9% (1) 1.00
OSA/CPAP 4.3% (2) 6.7% (2) 0% (0) 0.53
Chronic constipation 38.3% (18) 40.0% (12) 35.3% (6) 1.00
Preoperative SUI 68.1% (32) 60.0% (18) 82.4% (14) 0.19
Preoperative UUI 34.0% (16) 40.0% (12) 23.5% (4) 0.34
POP stage
Stage 2 55.3% (26) 63.3% (19) 41.2% (7) 0.22
Stage 3 44.7% (21) 36.7% (11) 58.8% (10) 0.22

Data presented as mean ± SD, median (range), and % (n)

SSLH sacrospinous ligament hysteropexy, USLH uterosacral ligament hysteropexy, COPD chronic obstructive pulmonary disease, OSA/CPAP obstructive sleep apnea, continuous positive airway pressure, SUI stress urinary incontinence, UUI urgency urinary incontinence